Search Within

Joachim Yahalom

  1. "CTCR Scholars"
Formats
  1. Meeting Abstract (45)
  2. Journal Article (15)
  3. Research Letter (2)
Groups
  1. CTCR Scholars (62)
  2. Center for Hematologic Malignancies (62)
  3. Department of Medicine (62)
  4. Hematologic Malignancies, Division of (62)
  5. Radiation Oncology, Department of (62)
  6. Survivorship Research (62)

More Groups

People
  1. Michael Scordo (45)
  2. Brandon Imber (40)
  3. Maria Palomba (36)
  4. Gunjan Shah (29)
  5. Parastoo Dahi (27)
  6. Connie Batlevi (26)

More People

Years
  1. 2025 (2)
  2. 2024 (9)
  3. 2023 (14)
  4. 2022 (9)
  5. 2021 (8)
  6. 2020 (8)

More Years

Publications
  1. Blood (18)
  2. Hematological Oncology (10)
  3. International Journal of Radiation Oncology, Biology, Physics (9)
  4. Neuro-Oncology (4)
  5. Blood Advances (3)
  6. Journal of Clinical Oncology (3)

More Publications

Publishers
  1. American Society of Hematology (21)
  2. Elsevier Inc. (15)
  3. Wiley Blackwell (10)
  4. Nature Publishing Group (4)
  5. Oxford University Press (4)
  6. American Society of Clinical Oncology (3)

More Publishers

Results (62)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Radiotherapy as an effective bridge for chemo‐refractory or progressive secondary CNS lymphoma
    Meeting Abstract

    Cederquist, G.; Tringale, K.; Hajj, C.; Hubbeling, H.; Sarkar, R.; Ma, J.; Dreyfuss, A.; Fregonese, B.; Lee, J.; Salles, G.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Dynamics of radiomic features following bridging therapy determine CD19 chimeric antigen receptor (CAR) T‐cell therapy outcome
    Meeting Abstract

    Imber, B. S.; Silverman, E. A.; Leithner, D.; Hubbeling, H.; Shah, G. L.; Fregonese, B.; Sanin, B. W.; Tomas, A. A.; Parascondola, A.; Saldia, A.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Bridging radiation rapidly and effectively cytoreduces high-risk relapsed/refractory aggressive B cell lymphomas prior to chimeric antigen receptor T cell therapy
    Journal Article

    Hubbeling, H.; Silverman, E. A.; Michaud, L.; Tomas, A. A.; Shouval, R.; Flynn, J.; Devlin, S.; Wijetunga, N. A.; Tringale, K. R.; Batlevi, C.; more...
    Transplantation and Cellular Therapy (2023)

    Fulltext@MSK | Save
  • Outcomes of patients with positive interim positron emission tomography (PET) continuing ABVD in the clinical setting
    Journal Article

    Zheng, S.; Gupta, K.; Goyal, P.; Nakajima, R.; Michaud, L.; Batlevi, C. L.; Hamlin, P. A.; Horwitz, S.; Kumar, A.; Matasar, M. J.; more...
    Cancers (2023)

    Fulltext@MSK | Save
  • Outcomes of first therapy after CD19-CAR-T treatment failure in large B-cell lymphoma
    Journal Article

    Alarcon Tomas, A.; Fein, J. A.; Fried, S.; Flynn, J. R.; Devlin, S. M.; Fingrut, W. B.; Anagnostou, T.; Alperovich, A.; Shah, N.; Fraint, E.; more...
    Leukemia (2023)

    Fulltext@MSK | Save
  • Radiotherapy for secondary CNS lymphoma: Patterns of utilization and clinical outcomes
    Meeting Abstract

    Cederquist, G. Y.; Tringale, K. R.; Hajj, C.; Hubbeling, H.; Fregonese, B.; Lee, J.; Scordo, M.; Grommes, C.; Yahalom, J.; Imber, B. S.
    Blood (2022)

    Fulltext@MSK | Save
  • Initial treatment response is prognostic and predictive of relapse patterns: Outcomes of >500 patients treated for primary CNS lymphoma
    Meeting Abstract

    Tringale, K. R.; Yahalom, J.; Scordo, M.; Cederquist, G. Y.; Vachha, B.; Schaff, L.; Hajj, C.; Hubbeling, H.; Zhang, Z.; White, C.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Identifying patterns of failure after initial therapy in primary CNS lymphoma in a large patient cohort
    Meeting Abstract

    Tringale, K.; Yahalom, J.; Scordo, M.; Vachha, B.; Schaff, L.; Grommes, C.; Imber, B.
    Neuro-Oncology (2022)

    Fulltext@MSK | Save
  • Patterns of relapse and risk reduction following tumor debulking by bridging radiotherapy prior to chimeric antigen receptor T cell therapy in non-Hodgkin lymphoma
    Meeting Abstract

    Hubbeling, H. G.; Silverman, E. A.; Michaud, L.; Flynn, J.; Devlin, S.; Wijetunga, N. A.; Alarcon Tomas, A.; Shouval, R.; Palomba, M. L.; Batlevi, C. L.; more...
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save
  • Radiotherapy for relapse after chimeric antigen receptor T cell therapy in hematologic malignancies
    Meeting Abstract

    Hubbeling, H. G.; Silverman, E. A.; Alarcon Tomas, A.; Tringale, K. R.; Wijetunga, N. A.; Hajj, C.; Mailankody, S.; Batlevi, C. L.; Dahi, P. B.; Giralt, S. A.; more...
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save